Heart disease and Alzheimers.

23andMe personalized DNA test seeks FDA approval Genetic check maker 23andMe is asking the Food and Medication Administration to approve its personalized DNA test in a move that, if successful, could increase acceptance of technology that is viewed by leading scientists who issue its usefulness skeptically. Online DNA mapping helps siblings find each other 23andMe is component of a fledgling market that allows customers to peek to their genetic code for details about their ancestry and future health. The company’s saliva-based packages possess attracted scrutiny for claiming to help users detect whether they will probably develop illnesses like breast cancer, heart disease and Alzheimer’s suhagra .